vs

Side-by-side financial comparison of Metalpha Technology Holding Ltd (MATH) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $12.0M, roughly 1.1× Metalpha Technology Holding Ltd). Metalpha Technology Holding Ltd runs the higher net margin — -24.0% vs -488.0%, a 464.0% gap on every dollar of revenue. On growth, OCULAR THERAPEUTIX, INC posted the faster year-over-year revenue change (-22.4% vs -39.0%).

Metalpha Technology Holding Ltd is a global fintech firm specializing in digital asset wealth management, institutional-grade crypto investment services, and Web3 ecosystem infrastructure support. It serves professional investors, financial institutions, and high-net-worth clients across Asia, North America and Europe, with core segments including structured digital asset products, risk management solutions and DeFi technology development.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

MATH vs OCUL — Head-to-Head

Bigger by revenue
OCUL
OCUL
1.1× larger
OCUL
$13.3M
$12.0M
MATH
Growing faster (revenue YoY)
OCUL
OCUL
+16.6% gap
OCUL
-22.4%
-39.0%
MATH
Higher net margin
MATH
MATH
464.0% more per $
MATH
-24.0%
-488.0%
OCUL

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
MATH
MATH
OCUL
OCUL
Revenue
$12.0M
$13.3M
Net Profit
$-2.9M
$-64.7M
Gross Margin
28.3%
88.0%
Operating Margin
-24.2%
-526.5%
Net Margin
-24.0%
-488.0%
Revenue YoY
-39.0%
-22.4%
Net Profit YoY
-147.7%
-33.6%
EPS (diluted)
$-0.07
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MATH
MATH
OCUL
OCUL
Q4 25
$13.3M
Q3 25
$12.0M
$14.5M
Q2 25
$13.5M
Q1 25
$24.8M
$10.7M
Q4 24
$17.1M
Q3 24
$19.7M
$15.4M
Q2 24
$16.4M
Q1 24
$14.8M
Net Profit
MATH
MATH
OCUL
OCUL
Q4 25
$-64.7M
Q3 25
$-2.9M
$-69.4M
Q2 25
$-67.8M
Q1 25
$9.8M
$-64.1M
Q4 24
$-48.4M
Q3 24
$6.0M
$-36.5M
Q2 24
$-43.8M
Q1 24
$-64.8M
Gross Margin
MATH
MATH
OCUL
OCUL
Q4 25
88.0%
Q3 25
28.3%
87.8%
Q2 25
85.6%
Q1 25
85.7%
88.2%
Q4 24
92.8%
Q3 24
49.5%
89.9%
Q2 24
90.8%
Q1 24
91.0%
Operating Margin
MATH
MATH
OCUL
OCUL
Q4 25
-526.5%
Q3 25
-24.2%
-472.3%
Q2 25
-502.6%
Q1 25
39.3%
-597.5%
Q4 24
-296.1%
Q3 24
38.9%
-298.2%
Q2 24
-265.1%
Q1 24
-214.0%
Net Margin
MATH
MATH
OCUL
OCUL
Q4 25
-488.0%
Q3 25
-24.0%
-477.3%
Q2 25
-503.9%
Q1 25
39.6%
-598.7%
Q4 24
-283.3%
Q3 24
30.7%
-236.6%
Q2 24
-266.3%
Q1 24
-438.9%
EPS (diluted)
MATH
MATH
OCUL
OCUL
Q4 25
$-0.27
Q3 25
$-0.07
$-0.38
Q2 25
$-0.39
Q1 25
$0.25
$-0.38
Q4 24
$-0.25
Q3 24
$0.16
$-0.22
Q2 24
$-0.26
Q1 24
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MATH
MATH
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$10.1M
$737.1M
Total DebtLower is stronger
$101.2K
Stockholders' EquityBook value
$35.1M
$654.3M
Total Assets
$413.8M
$808.1M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MATH
MATH
OCUL
OCUL
Q4 25
$737.1M
Q3 25
$10.1M
$344.8M
Q2 25
$391.1M
Q1 25
$6.9M
$349.7M
Q4 24
$392.1M
Q3 24
$3.8M
$427.2M
Q2 24
$459.7M
Q1 24
$482.9M
Total Debt
MATH
MATH
OCUL
OCUL
Q4 25
Q3 25
$101.2K
Q2 25
Q1 25
$188.0K
Q4 24
Q3 24
$275.1K
Q2 24
Q1 24
Stockholders' Equity
MATH
MATH
OCUL
OCUL
Q4 25
$654.3M
Q3 25
$35.1M
$258.2M
Q2 25
$305.9M
Q1 25
$36.6M
$265.9M
Q4 24
$315.3M
Q3 24
$25.3M
$352.0M
Q2 24
$377.7M
Q1 24
$408.0M
Total Assets
MATH
MATH
OCUL
OCUL
Q4 25
$808.1M
Q3 25
$413.8M
$410.9M
Q2 25
$451.3M
Q1 25
$246.8M
$405.9M
Q4 24
$457.9M
Q3 24
$237.2M
$490.4M
Q2 24
$517.1M
Q1 24
$538.9M
Debt / Equity
MATH
MATH
OCUL
OCUL
Q4 25
Q3 25
0.00×
Q2 25
Q1 25
0.01×
Q4 24
Q3 24
0.01×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MATH
MATH
OCUL
OCUL
Operating Cash FlowLast quarter
$3.3M
$-54.2M
Free Cash FlowOCF − Capex
$-57.1M
FCF MarginFCF / Revenue
-430.9%
Capex IntensityCapex / Revenue
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MATH
MATH
OCUL
OCUL
Q4 25
$-54.2M
Q3 25
$3.3M
$-50.7M
Q2 25
$-55.2M
Q1 25
$16.2M
$-44.7M
Q4 24
$-39.4M
Q3 24
$-16.1M
$-36.6M
Q2 24
$-24.8M
Q1 24
$-33.9M
Free Cash Flow
MATH
MATH
OCUL
OCUL
Q4 25
$-57.1M
Q3 25
$-56.7M
Q2 25
$-56.5M
Q1 25
$-46.6M
Q4 24
$-39.6M
Q3 24
$-36.6M
Q2 24
$-25.5M
Q1 24
$-34.1M
FCF Margin
MATH
MATH
OCUL
OCUL
Q4 25
-430.9%
Q3 25
-390.0%
Q2 25
-419.7%
Q1 25
-435.6%
Q4 24
-232.0%
Q3 24
-237.6%
Q2 24
-155.4%
Q1 24
-231.1%
Capex Intensity
MATH
MATH
OCUL
OCUL
Q4 25
21.4%
Q3 25
41.2%
Q2 25
9.3%
Q1 25
18.1%
Q4 24
1.2%
Q3 24
0.6%
Q2 24
4.5%
Q1 24
1.7%
Cash Conversion
MATH
MATH
OCUL
OCUL
Q4 25
Q3 25
Q2 25
Q1 25
1.64×
Q4 24
Q3 24
-2.66×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons